Spleen Tyrosine Kinase (Syk) Inhibitor Therapeutics – Pipeline Analysis – PhramaProff

Press Release

Spleen tyrosine kinase (Syk) is a protein that belongs to the family of tyrosine kinases with an ability to initiate the inflammatory responses, by connecting immune cell receptors to intracellular signaling pathways. Therefore, Syk is an attractive target for improving the symptoms related to acute and chronic inflammation. In addition, the role of protein is recognized as a promoter in various types of cancers ranging from leukemia to retinoblastoma. Syk protein facilitates the phosphorylation of protein on tyrosines and also involves in the B cell antigen receptor (BCR) signalling pathways. There are several drugs that effectively inhibit the Syk kinase but the off-target effect is a limiting factor. Currently, there are various Syk inhibitors that prevent release of inflammatory cytokines in vitro and IgE-driven mast cell degranulation.

Request to Get the Sample Pages at:   https://www.pharmaproff.com/request-sample/1198

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Read More….

About Pharma Proff

Pharma Proff, a brainchild of Prescient & Strategic (P&S) Intelligence Private Limited, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

We, at Pharma Proff, offer comprehensive reports in addition to providing pragmatic consultancy solutions to help our clients develop business strategies—critical to operations, R&D, product commercialization, and collaborations—that warrant enduring and sustainable results.

On the cusp of a new era that celebrates and lives by technology and holds immense potential for growth in the healthcare and pharmaceutical segments, we ensure our clients remain abreast of the changing industry landscape, comprehend the market dynamics analytically, and channelize their resources efficiently to maintain their stronghold in the market.

Contact:

Pharma Proff

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: [email protected]

Web: https://www.pharmaproff.com/

Connect with us: LinkedIn | Twitter | Facebook

This post was originally published on Financial Sector

Comments are closed.